Skip to main content

Table 1 Baseline sociodemographic and clinical characteristics of older breast cancer survivors

From: The impact of an exercise program on quality of life in older breast cancer survivors undergoing aromatase inhibitor therapy: a randomized controlled trial

Variables

Exercise Group (n = 18)

Control Group (n = 18)

p value

Age

63.2 ± 7.1

66.6 ± 9.6

0.23

Total Mass (kg)

28.9 ± 5.2

31.5 ± 6.2

0.19

Height (cm)

154.1 ± 6.7

153.1 ± 4.5

0.33

BMI

66.9 ± 10.3

72.3 ± 13.1

0.18

Level of Schooling (%)

 No schooling

11.8

22.2

 

 Basic education

35.2

27.8

0.73

 High school

23.6

27.8

 

 Higher education

29.4

22.2

 

Marital Status (%)

 Single

11.1

5.6

 

 Married

61.1

55.6

0.53

 Divorced

5.6

0

 

 Widowed

22.2

38.9

 

Occupation (%)

 Housewife

55.6

50

 

 Works

5.6

16.7

0.27

 Retired

38.9

33.3

 

Children (%)

 No

5.6

5.6

0.82

 yes

94.4

94.4

 

Cancer Stage (%)

 I

50

58.8

 

 II

33.3

23.6

0.74

 III

17.6

17.6

 

Type of Surgery (%)

 Partial mastectomy

47.4

58.8

0.73

 Total mastectomy

52.6

41.2

 

General Treatment Received (%)

 Chemotherapy

66.6

69.3

0.31

 Radiotherapy

77.8

75.2

0.10

 Chemotherapy and Radiotherapy

50

38.9

0.50

Time of use of AI (months)

19.3 ± 8.3

17.9 ± 11.2

0.66

Number of diseases (%)

 2 diseases

27.8

16.7

0.53

 More than 2 diseases

72.8

83.3

 

Medicine used in a continuous manner

 2 medicine

22.2

24.8

0.97

 More than 2 medicine

77.8

75.2

 
  1. BMI body mass index, AI aromatase inhibitors; numerical variables expressed as mean and standard deviation. Categorical variables expressed as %. No statistically significant baseline differences between groups